Processa Pharmaceuticals doses first subject in Phase II breast cancer trial
Processa Pharmaceuticals has dosed the first subject in its Phase II clinical trial of Next Generation Capecitabine (NGC-Cap) to treat …
Processa Pharmaceuticals has dosed the first subject in its Phase II clinical trial of Next Generation Capecitabine (NGC-Cap) to treat …
The National Institutes of Health (NIH) unit of the National Institute of Allergy and Infectious Diseases (NIAID) has selected Emergex …
Qnovia has received clearance from the US Food and Drug Administration (FDA) to start a clinical trial for its RespiRX …
SetPoint Medical has been given an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) greenlighting it …
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess the combination of casdatifan (AB521) and volrustomig in …
UroGen Pharma has announced the dosing of the first subject in the Phase III UTOPIA clinical trial of its investigational …
Biostatistics has found applications in several clinical research fields such as clinical studies, epidemiology, population genetics, and systems biology. Thus, …
As AI continues to disrupt the healthcare industry, more pharma companies are using algorithms to design drug molecules. AI-driven pharma tech …
Barinthus Biotherapeutics (formerly Vaccitech) has completed enrolment for its vaccine trials in chronic hepatitis B (CHB) and prostate cancer. The UK-based …
A diarrhoea drug by Jaguar Health that previously failed in a Phase III oncology trial has shown statistically significant benefit …
Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT …
A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction …
Early adoption of artificial intelligence (AI) is already changing the game in clinical trials, with AI enabling some companies to …
EmVenio Research recently announced it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas. …
Clinical research organization EmVenio Research, a PCM Trials company, recently celebrated its partnership with Prime Healthcare in a grand opening event …